Sparton Corporation (SPA) To Manufacture PathoGenetix RESOLUTION Microbial Genotyping System
2/3/2014 8:23:23 AM
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Sparton Corporation (NYSE:SPA) has been chosen by PathoGenetix, Inc. as the design and manufacturing partner for their RESOLUTION™ Microbial Genotyping System. PathoGenetix, is a developer of an automated system for rapid bacterial strain typing. Under the terms of the agreement, Sparton will conduct design for manufacture and pilot production of a limited number of pre-commercial instruments for the RESOLUTION System, which is slated for commercial availability in late 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by